Jennifer L. Lessor

Jennifer L. Lessor, MPH, is an accomplished executive specializing in market access and health economics within the biopharmaceutical industry. Currently serving as Vice President of Cell Therapy Market Access at Miltenyi Biomedicine since July 2025, Jennifer previously held the position of Head of Market Access and Economics at BioLineRx, where responsibilities included implementing successful market access strategies for the launch of Aphexda. With extensive experience in various roles, including independent consulting for Oncopeptides AB and a Director position at Sanofi Genzyme, Jennifer has established a strong track record in pricing strategy, payer relations, and specialty distribution. Educational qualifications include a Master’s degree in Public Health from The University of Texas Health Science Center at Houston and multiple certifications in project management and health economics.